…based in Vilnius, Lithuania, was set up to broaden the range of Cas proteins that can snip DNA. This could allow edits to be made in more sites in the…
…based on early clinical data. Both the candidates designed to induce cell death by interrupting DNA replication, boosted antitumor activity in patients. Another ADC in the limelight was British multinational…
…DNA instructions to the liver, where factor IX proteins are then generated. These genetic instructions remain in the target cells but generally do not become a part of a person’s…
…company ViiV Healthcare in collaboration with Janssen, this monthly treatment is a combination of two drugs. One, called rilpirivine, blocks the protein that turns the virus’ genetic material into DNA….
…in Europe was restricted to organisms obtained through transgenesis techniques, which insert DNA from a different species into an organism. In contrast, mutagenesis techniques manipulate the organism’s own DNA without…
…materials with biological components, such as cells, proteins or DNA. This requires the collaboration of researchers from several branches of science. “In robotics we see materials scientists and biologists working…
…molecules. This trend was punctuated by a €30M Series C closing from another DNA producer — DNA Script — earlier in the month. Biotech seed investments in January 2022 were…
…proteins, which repair damaged DNA. A mutation in one of these genes increases the risk of breast cancer by up to 25% and can cause it to develop at a…
…x 13.5”. DNA, keratin, Ethylene-Vinil. “Synaptic Kiss” (2013). 9″ x 9″ x 12″. Keratin and DNA. Günes-Hélène Istan (from Turkey, Canada-based) Günes-Hélène examines our dependence on other species and imagines…
…ancestors, leaving viral DNA in around 8% of the human genome. This viral DNA is rarely active, but there is evidence that proteins encoded by the viral DNA contribute to…
…collect blood samples in hopes that the murderer has left traces of DNA. After sampling, the student accesses a virtual lab to perform DNA analysis. The majority of the case…
Solu, founded in 2022, is a Finnish biotechnology company focusing on combating antibiotic resistance by building the world’s most extensive pathogen DNA library. Solu’s product makes understanding, detecting, and preventing…